Amit Sachdev - 09 Feb 2024 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
09 Feb 2024
Transactions value $
-$2,208,794
Form type
4
Date filed
13 Feb 2024, 17:15
Previous filing
08 Feb 2024
Next filing
21 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability -$855K -2.02K -2.54% $422.74 77.6K 09 Feb 2024 Direct
transaction VRTX Common Stock Sale -$1.35M -3.22K -4.15% $420.24 74.4K 12 Feb 2024 Direct F1
holding VRTX Common Stock 882 09 Feb 2024 401(k)
holding VRTX Common Stock 6.57K 09 Feb 2024 Held in Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1, which was entered into on 05/09/2023.